Alnylam Pharmaceuticals Cambridge, USA
Alnylam is a leading biopharmaceutical company and pioneer in RNA interference (RNAi) therapeutics, a revolutionary approach to treating diseases by silencing genes that cause or contribute to them. Founded in 2002, the company has developed multiple approved RNAi therapeutic medicines and maintains a pipeline of therapies for rare and prevalent diseases. The company operates globally with offices across North America, Europe, Asia, and South America.
Hiring at Alnylam Pharmaceuticals? Claim this page.
Open positions
- The Key Account Manager (KAM) is a field-based expert, that strategically drives the commercial objectives of selected genetic programs for Germany in the assigned territory. The KAM will be…
-
Not sure which role fits?
Create a profile to see your match score for every Alnylam Pharmaceuticals role.
Create free profileFree · takes 30 seconds